The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | N | Nervous system | |
| 2 | N05 | Psycholeptics | |
| 3 | N05A | Antipsychotics | |
| 4 | N05AA | Phenothiazines with aliphatic side-chain |
| Code | Title | |
|---|---|---|
| N05AA01 | Chlorpromazine | |
| N05AA02 | Levomepromazine | |
| N05AA03 | Promazine | |
| N05AA04 | Acepromazine | |
| N05AA05 | Triflupromazine | |
| N05AA06 | Cyamemazine | |
| N05AA07 | Chlorproethazine |
| Active Ingredient | Description | |
|---|---|---|
| Chlorpromazine |
Chlorpromazine is a phenothiazine neuroleptic. Chlorpromazine has depressant actions on the Central Nervous System, with alpha-adrenergic blocking and anticholinergic activities. It has anti-emetic, anti-puritic, serotonin-blocking and weak anti-histamine properties and slight ganglion blocking activity. |
|
| Levomepromazine |
Levomepromazine resembles chlorpromazine and promethazine in the pattern of its pharmacology. It possesses anti-emetic, antihistamine and anti-adrenaline activity and exhibits a strong sedative effect. |
|
| Promazine |
Promazine has a wide range of activity arising from its depressant actions on the central nervous system and its alpha-adrenergic blocking and weaker anticholinergic activities. Promazine is a dopamine inhibitor. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| CHLORPROMAZINE Film-coated tablet | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| LARGACTIL Solution for injection | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| NOZINAN Solution for injection / infusion | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| NOZINAN Tablets | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
